ANTITUMOR COMBINATION COMPRISING AN AROMATASE INHIBITOR AND AN EGFR ANTAGONIST OR INHIBITOR

摘要

A method of treating a human being suffering from a hormone-dependent disorder characterized by the overexpression of EGFR, comprising administering to said human being an aromatase inhibitor and an EGFR antagonist or EGFR inhibitor, in amounts effective to produce a superadditive or synergistic therapeutic effect.